GlaxoSmithKline is downgraded to 'underperform,' while AstraZeneca is upgraded to 'neutral.'
If Bernanke passes on more QE, these companies are likely to feel some pain.
Despite the drought, these companies are set to benefit from a long-term global boom in agriculture.
The electronics retailers is reportedly a buyout candidate, and the media company will decide about splitting into 2.
These US-listed investments can grab a large stake in global trends without the high fees and difficulty of investing in individual stocks abroad.
Ariad Pharmaceuticals, Monsanto and Accenture are a few names that could benefit if these events come to pass.
Despite the debt crisis in Europe, this worthy agribiz stock deserves investor attention.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The offering could become the second-biggest this year if underwriters exercise an option to buy more shares.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.